Coagulation Factor VIIa (Recombinant)
F7TG2202
Phase 3 mab terminated
Quick answer
Coagulation Factor VIIa (Recombinant) for Hemophilia is a Phase 3 program (mab) at Laboratoire HRA Pharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Laboratoire HRA Pharma
- Indication
- Hemophilia
- Phase
- Phase 3
- Modality
- mab
- Status
- terminated